P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome

P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome have?

P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome has 1 citations in the OpenAlex counts ScholarIQ stores.

When was P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome published?

P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome has 2023 year in the ScholarIQ index.

What is the open-access status of P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome?

P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome has bronze oa status in the ScholarIQ index.

What is the DOI of P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome?

The DOI for P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome is on the source record.

What is the OpenAlex record for P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome?

The OpenAlex for P395 Short-term clinical efficacy and safety of teduglutide for Crohn’s disease patients with short bowel syndrome is on the source record.